“Cancer pain remains poorly understood and there are no effective therapies…
We tested whether a local CBr2 agonist produces antinociception. Our findings suggest that a peripheral CBr2 agonist could provide relief for cancer patients. Cannabinoids also potentiate the analgesic effects of morphine and prevent tolerance.
These desirable effects of cannabinoids show promise for management of cancer pain and may lead to improved analgesic therapy.
These findings support the suggestion that cannabinoids are capable of producing antinociception in carcinoma-induced pain.”